PENAO Company
PENAO is focused on the research, development and commercialization of the potential anti-cancer small molecule drug.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Sydney, New South Wales, Australia
Founded Date:
2019
Funding Status:
M&A
Register and Claim Ownership